Literature DB >> 26878973

Sonoporation enhances liposome accumulation and penetration in tumors with low EPR.

Benjamin Theek1, Maike Baues1, Tarun Ojha1, Diana Möckel1, Seena Koyadan Veettil2, Julia Steitz2, Louis van Bloois3, Gert Storm4, Fabian Kiessling5, Twan Lammers6.   

Abstract

The Enhanced Permeability and Retention (EPR) effect is a highly variable phenomenon. To enhance EPR-mediated passive drug targeting to tumors, several different pharmacological and physical strategies have been evaluated over the years, including e.g. TNFα-treatment, vascular normalization, hyperthermia and radiotherapy. Here, we systematically investigated the impact of sonoporation, i.e. the combination of ultrasound (US) and microbubbles (MB), on the tumor accumulation and penetration of liposomes. Two different MB formulations were employed, and their ability to enhance liposome accumulation and penetration was evaluated in two different tumor models, which are both characterized by relatively low levels of EPR (i.e. highly cellular A431 epidermoid xenografts and highly stromal BxPC-3 pancreatic carcinoma xenografts). The liposomes were labeled with two different fluorophores, enabling in vivo computed tomography/fluorescence molecular tomography (CT-FMT) and ex vivo two-photon laser scanning microscopy (TPLSM). In both models, in spite of relatively high inter- and intra-individual variability, a trend towards improved liposome accumulation and penetration was observed. In treated tumors, liposome concentrations were up to twice as high as in untreated tumors, and sonoporation enhanced the ability of liposomes to extravasate out of the blood vessels into the tumor interstitium. These findings indicate that sonoporation may be a useful strategy for improving drug targeting to tumors with low EPR.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EPR; Liposomes; Microbubbles; Sonoporation; Ultrasound

Mesh:

Substances:

Year:  2016        PMID: 26878973      PMCID: PMC5404719          DOI: 10.1016/j.jconrel.2016.02.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  57 in total

Review 1.  Looking and listening to light: the evolution of whole-body photonic imaging.

Authors:  Vasilis Ntziachristos; Jorge Ripoll; Lihong V Wang; Ralph Weissleder
Journal:  Nat Biotechnol       Date:  2005-03       Impact factor: 54.908

2.  FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography.

Authors:  Angelique Ale; Vladimir Ermolayev; Eva Herzog; Christian Cohrs; Martin Hrabé de Angelis; Vasilis Ntziachristos
Journal:  Nat Methods       Date:  2012-05-06       Impact factor: 28.547

3.  Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model.

Authors:  Sandra N Ekdawi; James M P Stewart; Michael Dunne; Shawn Stapleton; Nicholas Mitsakakis; Yannan N Dou; David A Jaffray; Christine Allen
Journal:  J Control Release       Date:  2015-04-08       Impact factor: 9.776

Review 4.  Acoustic behavior of microbubbles and implications for drug delivery.

Authors:  Klazina Kooiman; Hendrik J Vos; Michel Versluis; Nico de Jong
Journal:  Adv Drug Deliv Rev       Date:  2014-03-23       Impact factor: 15.470

5.  New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.

Authors:  Steliyan Tinkov; Conrad Coester; Susanne Serba; Nicolas A Geis; Hugo A Katus; Gerhard Winter; Raffi Bekeredjian
Journal:  J Control Release       Date:  2010-09-22       Impact factor: 9.776

6.  A nanoparticle size series for in vivo fluorescence imaging.

Authors:  Zoran Popović; Wenhao Liu; Vikash P Chauhan; Jungmin Lee; Cliff Wong; Andrew B Greytak; Numpon Insin; Daniel G Nocera; Dai Fukumura; Rakesh K Jain; Moungi G Bawendi
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-08       Impact factor: 15.336

7.  Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors.

Authors:  Juan Kang; Xiaoling Wu; Zhigang Wang; Haitao Ran; Chuanshan Xu; Jinfeng Wu; Zhaoxia Wang; Yong Zhang
Journal:  J Ultrasound Med       Date:  2010-01       Impact factor: 2.153

8.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  Image-guided drug delivery: preclinical applications and clinical translation.

Authors:  Tarun Ojha; Larissa Rizzo; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Expert Opin Drug Deliv       Date:  2015-06-17       Impact factor: 6.648

10.  The Theranostic Path to Personalized Nanomedicine.

Authors:  Benjamin Theek; Larissa Y Rizzo; Josef Ehling; Fabian Kiessling; Twan Lammers
Journal:  Clin Transl Imaging       Date:  2014-02-01
View more
  29 in total

1.  Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.

Authors:  Joshua VanOsdol; Kalyani Ektate; Selvarani Ramasamy; Danny Maples; Willie Collins; Jerry Malayer; Ashish Ranjan
Journal:  J Control Release       Date:  2016-12-30       Impact factor: 9.776

2.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 3.  Standardization of Small Animal Imaging-Current Status and Future Prospects.

Authors:  Julia G Mannheim; Firat Kara; Janine Doorduin; Kerstin Fuchs; Gerald Reischl; Sayuan Liang; Marleen Verhoye; Felix Gremse; Laura Mezzanotte; Marc C Huisman
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

Review 4.  Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

Authors:  Yuko Nakamura; Ai Mochida; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2016-09-02       Impact factor: 4.774

5.  G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma.

Authors:  Zhiping Yu; Yixuan Wang; Dan Xu; Lianhua Zhu; Ming Hu; Qiuli Liu; Weihua Lan; Jun Jiang; Luofu Wang
Journal:  Int J Nanomedicine       Date:  2020-01-08

6.  Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.

Authors:  Benjamin Theek; Maike Baues; Felix Gremse; Robert Pola; Michal Pechar; Inka Negwer; Kaloian Koynov; Benjamin Weber; Matthias Barz; Willi Jahnen-Dechent; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  J Control Release       Date:  2018-05-04       Impact factor: 9.776

Review 7.  Enhancing Tumor Penetration of Nanomedicines.

Authors:  Qingxue Sun; Tarun Ojha; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Biomacromolecules       Date:  2017-03-31       Impact factor: 6.988

8.  PBCA-based polymeric microbubbles for molecular imaging and drug delivery.

Authors:  Patrick Koczera; Lia Appold; Yang Shi; Mengjiao Liu; Anshuman Dasgupta; Vertika Pathak; Tarun Ojha; Stanley Fokong; Zhuojun Wu; Marc van Zandvoort; Olga Iranzo; Alexander J C Kuehne; Andrij Pich; Fabian Kiessling; Twan Lammers
Journal:  J Control Release       Date:  2017-03-06       Impact factor: 9.776

Review 9.  Ultrasound-mediated drug delivery to the brain: principles, progress and prospects.

Authors:  Anshuman Dasgupta; Mengjiao Liu; Tarun Ojha; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Drug Discov Today Technol       Date:  2016-10-25

Review 10.  Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.

Authors:  Tarun Ojha; Vertika Pathak; Yang Shi; Wim E Hennink; Chrit T W Moonen; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.